Safety of thimerosal containing vaccines. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society;Seguridad de las vacunas que contienen timerosal: Declaración del Comité Consultivo de Inmunizaciones (CCI) de la Sociedad Chilena de Infectología

Revista Chilena de Infectologia

Volumn 24, Issue 5, 2007, Pages 372-376

  Muñoz Muñoz, Alma ^a   Abarca V , Katia ^a   Jiménez De La J , Jorge ^a   Luchsinger F , Vivian ^a   O'Ryan G , Miguel ^a   Ripoll M , Erna ^a   Valenzuela B , M Teresa ^a   Vergara F , Rodrigo ^a  

^a NONE

Author keywords

Ethylmercury; Safety; Thimerosal; Thiomersal; Vaccines

Indexed keywords

PRESERVATIVE; THIOMERSAL; VACCINE;

AUTISM; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHILD; CHILE; HUMAN; INFANT; MEDICAL SOCIETY; REVIEW; STANDARD;

AUTISTIC DISORDER; CHILD; CHILE; HUMANS; INFANT; PRESERVATIVES, PHARMACEUTICAL; REFERENCE STANDARDS; SOCIETIES, MEDICAL; THIMEROSAL; VACCINES;

EID: 36249027667     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Agency for Toxic Substances and Disease Registry. U.S. Department of Health and Human Services. Toxicological Profile of Mercury. March 1999.
2. Clarkson T W, Magos L, Myers G J. The toxicity of mercury: current exposures and clinical manifestations. N Engl J Med 2003; 349: 1731-7.
3. Zambrano B. Consideraciones generales sobre el mercurio, el timerosal, y su uso en vacunas pediátricas. Rev Med Uruguay 2004; 20: 4-11.
4. Pichichero M E, Cernichiari E, Lopreiato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet 2002; 360: 1737-41.
5. Clements C J, Ball L K, Ball R, Pratt R D. Thiomersal in vaccines: is removal warranted? Drug Safety 2001; 24: 567-74.
6. Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines. Pediatrics 2001; 107: 1147-54.
7. Bigham M, Copes R. Thimerosal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease. Drug Safety 2005; 28: 89-101.
8. World Health Organization. Global Advisory Committee on Vaccine Safety. Safety of thimerosal-containing vaccines. 20-21 June 2002. WER 2002; 77: 389-90.
9. Food and Drug Administration. Center for Biologics Evaluation and Research (CBER). Thimerosal in vaccines. www.fda.gov/cber/vaccine/thimerosal. (Accedido: 27 de julio, 2006).
10. Freed G L, Andreae M C, Cowan A E, Katz S L. The process of public policy formulation: The case of thimerosal in vaccines. Pediatrics 2002; 109: 1153-9.
11. Clarkson T W. The three faces of mercury. Environ Health Perspect 2002; 110 (Suppl 1): 11-23.
12. Clements C J. The evidence for the safety of thimerosal in newborn and infant vaccines. Vaccine 2004; 22: 1854-61.
13. Thimerosal content in some US licensed vaccines. www.vaccinesafety.edu/ thi-table-Oct1606.pdf. (Accedido: 26 de marzo, 2007).
14. Anónimo. World Health Organization guidelines on regulatory expectations related to the elimination, reduction or replacement of thiomersal in vaccines. Technical Report Series No 926, 2004.
15. Parker S, Schwartz B, Todd J, Pickering L. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 2004; 114; 793-804.
16. Geier M R, Geier D A. Neurodevelopmental disorders after thimerosal containing vaccines: a brief communication. Exp Biol Med (Maywood) 2003; 228: 660-4.
17. Geier D A, Geier M R. Thimerosal in childhood vaccines, neurodevelopmental disorders, and heart disease in the United States. J Am Phys Surg 2003; 8: 6-11.
18. Geier D A, Geier M R. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatr Rehabil 2003; 6: 97-102.
19. Geier D A, Geier M R. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit 2004; 10: PI33-9.
20. Stajich G V, Lopez G P, Harry S W, Sexson W R. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J Pediatr 2000; 136: 679-81.
21. Heron J, Golding J, and the ALSPAC Study Team. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004; 114; 577-83.
22. Andrews A, Miller E, Grant A, Stowe J Osborne V, Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004; 114: 584-91.
23. Cox N H, Forsyth A. Thimerosal allergy and vaccination reactions. Contact Dermatitis 1988; 18: 229-33.
24. Goncalo M, Figueiredo A, Goncalo S. Hypersensitivity to thimerosal: the sensitivity moiety. Contact Dermatitis 1996; 34: 201-3.
25. Food and Drug Administration. Center for Drugs Evaluation and Research (CDER). Mercury compounds in drugs and food. www.fda.gov/cder/fdama/ mercuryreport.htm. (Accedido: 27 de julio 2006).
26. CDC. Notice to readers: Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morbid Mortal Wkly Rep 1999; 48 (26): 563-5.
27. World Health Organization. Thimerosal as a vaccine preservative. WER 2000; 75: 12-6.
28. World Health Organization. Meeting Report. Thimerosal in vaccines: A regulatory perspective. Geneva, 15-16 April 2002.
29. Egan W. Statement before the Committee on Government Reform. U.S. House of Representatives July 18, 2000 www.fda.gov/ola/2000/vaccines.html (Accedido 27 de abril 2007).
30. Stratton K, Gable A, McCormick M, Editors. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention Institute of Medicine of the National Academies. The National Academic Press. 2001.
31. Immunization Safety Review Committee. Board on Health Promotion and Disease Prevention. Institute of Medicine of the National Academies. Immunization Safety Review. Vaccines and Autism. The National Academic Press. 2004.
32. Burbacher T M, Shen D D, Liberato N, Grant K S, Cernichiari E, Clarkson T. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environmental Health Perspectives 2005; 113: 1015-21.
33. World Health Organization. Global Advisory Committee on Vaccine Safety. Thimerosal: neurobehavioural studies in animal models. WER 2005; 80: 1-8.